Azeliragon T2507
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Azeliragon is an antagonist at the Receptor for Advanced Glycation End products; is evaluated as a potential treatment for patients with mild-to-moderate Alzheimer_acute_s disease (AD).
CAS nr:
603148-36-3
Purity:
98%
Molecular Weight:
532,12
SMILES:
CCCCc1nc(cn1c1ccc(cc1)Oc1ccc(cc1)Cl)c1ccc(cc1)OCCCN(CC)CC
Formula:
C32H38ClN3O2
Pathway:
Others,Neuroscience
Target:
advanced glycation end products,Beta Amyloid
